Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt · Delayed Price · Currency is EGP 85.89
-0.29 (-0.34%)
At close: Apr 23, 2026
EGX:PHAR Revenue
In the year 2025, Egyptian International Pharmaceutical Industries Company had annual revenue of 9.44B EGP with 24.38% growth. Egyptian International Pharmaceutical Industries Company had revenue of 2.28B in the quarter ending December 31, 2025, with 6.78% growth.
Revenue
9.44B
Revenue Growth
+24.38%
P/S Ratio
1.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.44B | 1.85B | 24.38% |
| Dec 31, 2024 | 7.59B | 2.36B | 45.09% |
| Dec 31, 2023 | 5.23B | 1.28B | 32.27% |
| Dec 31, 2022 | 3.96B | 546.35M | 16.03% |
| Dec 31, 2021 | 3.41B | 523.18M | 18.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition